Device Cardiovascular and Vascular Surgery

Jotec Products

Payments companies reported to CMS as associated with Jotec Products. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$30Kassociated payments (2023-2025)
64clinicians with associated payments
1company reporting

By year

2023 $1,511
2024 $6,789
2025 $22K

Payments reported as associated with Jotec Products, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Thoracic Surgery (Cardiothoracic Vascular Surgery) $15K
Vascular Surgery $14K
Internal Medicine $242
Surgery $220
Vascular & Interventional Radiology $199
Anesthesiology $121

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Jotec Products

These are the largest totals companies reported as associated with Jotec Products. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Elbert Williams New York, NY Thoracic Surgery (Cardiothoracic Vascular Surgery) $2,643.94
Bernardo Curi Mendes Los Angeles, CA Vascular Surgery $2,354.41
Mark Farber Chapel Hill, NC Vascular Surgery $2,354.41
Fernando Fleischman Los Angeles, CA Thoracic Surgery (Cardiothoracic Vascular Surgery) $2,321.63
Luis Sanchez Saint Louis, MO Vascular Surgery $2,300.00
Juan Umana Miami, FL Thoracic Surgery (Cardiothoracic Vascular Surgery) $2,250.00
Frank Arko Charlotte, NC Vascular Surgery $1,800.00
Sukgu Han Los Angeles, CA Vascular Surgery $1,800.00
Himanshu Patel Ann Arbor, MI Thoracic Surgery (Cardiothoracic Vascular Surgery) $1,500.00
Cherrie Abraham Portland, OR Vascular Surgery $800.00

Prescribed Jotec Products?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.